Literature DB >> 2916977

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years.

R Klein1, B E Klein, S E Moss, M D Davis, D L DeMets.   

Abstract

Population-based epidemiologic data on the incidence and progression of diabetic retinopathy are important in medical counseling and rehabilitative services and for developing approaches to preventing diabetic retinopathy. We performed a population-based study in southern Wisconsin of insulin-taking diabetic persons diagnosed before 30 years of age. Of the 271 who had no retinopathy at the first visit, 160 (59%) developed it by the time they were reexamined four years later, and 75 (11%) of the 713 free of proliferative diabetic retinopathy developed it. Overall, worsening of retinopathy occurred in 41% of the population, whereas improvement occurred in only 7%. The incidence of proliferative retinopathy rose with increasing duration until 13 to 14 years of diabetes, thereafter remaining between 14% and 17%. These incidence data underscore the need for careful ophthalmologic follow-up of these people.

Entities:  

Mesh:

Year:  1989        PMID: 2916977     DOI: 10.1001/archopht.1989.01070010243030

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  89 in total

1.  Inflammatory and endothelial dysfunction markers and proteinuria in persons with type 1 diabetes mellitus.

Authors:  Karine Sahakyan; Barbara E K Klein; Kristine E Lee; Michael Y Tsai; Ronald Klein
Journal:  Eur J Endocrinol       Date:  2010-03-23       Impact factor: 6.664

2.  Crossing the evidence chasm: building evidence bridges from process changes to clinical outcomes.

Authors:  David C Kendrick; Davis Bu; Eric Pan; Blackford Middleton
Journal:  J Am Med Inform Assoc       Date:  2007-02-28       Impact factor: 4.497

3.  Requisite models for strategic commissioning: the example of type 1 diabetes.

Authors:  Mara Airoldi; Gwyn Bevan; Alec Morton; Mónica Oliveira; Jenifer Smith
Journal:  Health Care Manag Sci       Date:  2008-06

4.  Ten-year change in self-rated quality of life in a type 1 diabetes population: Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Authors:  Flavio E Hirai; James M Tielsch; Barbara E K Klein; Ronald Klein
Journal:  Qual Life Res       Date:  2012-08-08       Impact factor: 4.147

5.  The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy.

Authors:  Ronald Klein; Kristine E Lee; Ronald E Gangnon; Barbara E K Klein
Journal:  Ophthalmology       Date:  2009-10-31       Impact factor: 12.079

6.  Loss of heparan sulphate proteoglycan and retinal microinfarcts in diabetes mellitus.

Authors:  M S Roy; M E Rick
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

Review 7.  Japanese Clinical Practice Guideline for Diabetes 2016.

Authors:  Masakazu Haneda; Mitsuhiko Noda; Hideki Origasa; Hiroshi Noto; Daisuke Yabe; Yukihiro Fujita; Atsushi Goto; Tatsuya Kondo; Eiichi Araki
Journal:  Diabetol Int       Date:  2018-03-27

8.  Diabetic Retinopathy: Focus on Minority Populations.

Authors:  Arpine Barsegian; Boleslav Kotlyar; Justin Lee; Moro O Salifu; Samy I McFarlane
Journal:  Int J Clin Endocrinol Metab       Date:  2017-11-11

9.  Patient self-report of prior laser treatment reliably indicates presence of severe diabetic retinopathy.

Authors:  Michael A Grassi; D Anthony Mazzulla; Michael D Knudtson; Wendy W Huang; Kristine E Lee; Barbara E Klein; Dan L Nicolae; Ronald Klein
Journal:  Am J Ophthalmol       Date:  2008-12-03       Impact factor: 5.258

10.  Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: a hospital-based study.

Authors:  Mahfouth A Bamashmus; Abdallah A Gunaid; Rajiv B Khandekar
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.